1.86
Precedente Chiudi:
$1.87
Aprire:
$1.79
Volume 24 ore:
63,967
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.60M
Reddito:
$1.41M
Utile/perdita netta:
$-7.36M
Rapporto P/E:
-0.1759
EPS:
-10.5747
Flusso di cassa netto:
$-7.07M
1 W Prestazione:
+24.83%
1M Prestazione:
-38.82%
6M Prestazione:
-67.48%
1 anno Prestazione:
-75.20%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.86 | 4.60M | 1.41M | -7.36M | -7.07M | -10.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded to Hold at Wall Street Zen - Defense World
60 Degrees Pharmaceuticals Inc. (SXTP) upgraded to buy: Here's what you should know - MSN
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know - sharewise.com
60 Degrees Pharmaceuticals Inc. (SXTP) Receives Buy Rating Upgrade: Key Information You Need - Bitget
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - thepublicopinion.com
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO) - The Globe and Mail
Portfolio Shifts: Will 60 Degrees Pharmaceuticals Inc outperform small cap indexes2026 Pullbacks & Accurate Buy Signal Alerts - baoquankhu1.vn
10-K: FY2025 Annual Report - Moomoo
60 Degrees Pharmaceuticals Reports 65% Increase in FY 2025 Net Product Revenues to $1.0 Million and Operational Developments - Quiver Quantitative
60 Degrees Pharmaceuticals Announces 2025 Annual Results - ChartMill
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
New financings back 60 Degrees Pharma (NASDAQ: SXTP) infectious disease pipeline - Stock Titan
Update Recap: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns2026 Decliners & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Wall Street Recap: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2026 Major Catalysts & Reliable Price Action Trade Plans - baoquankhu1.vn
Movement Recap: How is 60 Degrees Pharmaceuticals Inc managing supply chain issuesPortfolio Gains Summary & Daily Market Momentum Tracking - baoquankhu1.vn
Analyst Calls: Should I hold or sell 60 Degrees Pharmaceuticals Inc nowRisk Management & Reliable Breakout Forecasts - baoquankhu1.vn
Published on: 2026-03-26 13:08:49 - baoquankhu1.vn
Gap Down: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 Geopolitical Influence & Verified Trade Idea Suggestions - baoquankhu1.vn
Patterns Watch: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in 60 degrees pharmaceuticals, Inc. (SXTP) - Stock Titan
Performance Recap: Is 60 Degrees Pharmaceuticals Inc a momentum stock2026 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
60 Degrees Updates Affiliate Share Ownership Disclosure Error - The Globe and Mail
Aug Levels: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Corrects Prospectus Supplement Disclosure in SEC Form 8-K Filing (March 20, 2026) - Minichart
60 Degrees Pharmaceuticals corrects affiliate share counts in prospectus supplement - TradingView
Affiliate share ownership restated by 60 Degrees (NASDAQ: SXTP) - Stock Titan
Death Cross: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sector2026 Key Highlights & AI Powered Market Entry Ideas - baoquankhu1.vn
60 Degrees Pharma submits dietary supplement notification to FDA By Investing.com - Investing.com Australia
Bull Run: Can 60 Degrees Pharmaceuticals Inc sustain earnings growth2026 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
60 Degrees submits NDIN to FDA for Australian Chestnut Extract - TipRanks
60 Degrees Pharma submits dietary supplement notification to FDA - Investing.com
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract - TradingView
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - The Manila Times
Gains Report: Can 60 Degrees Pharmaceuticals Inc be recession proofInsider Buying & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Market Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sectorMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Volatility Watch: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2026 Valuation Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
60 Degrees Pharmaceuticals files updated legal opinion for at-the-market offering - Investing.com Nigeria
What's going on with 60 Degrees Pharmaceuticals on Friday? - MSN
60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion for ATM Equity Offering Program – March 2026 - Minichart
60 Degrees Pharmaceuticals files updated legal opinion for ATM equity program - Investing.com Australia
60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity - TradingView
60 Degrees Pharmaceuticals Updates Opinion for ATM Program - The Globe and Mail
60 Degrees (SXTP) updates ATM capacity to $565K after prior sales - Stock Titan
60 Degrees Pharmaceuticals (SXTP) updates legal opinion for at-the-market stock program - Stock Titan
What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
Quarterly Risk: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Files Form 8-K With NASDAQ Listing Details and Corporate Information - Minichart
60 Degrees Pharmaceuticals (NASDAQ: SXTP) updates legal opinion for ATM equity program - Stock Titan
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):